Publicacións nas que colabora con Luisa Maria Seoane Camino (14)

2022

  1. Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21

    Nature Metabolism, Vol. 4, Núm. 7, pp. 901-917

2021

  1. Circulating LEAP-2 is associated with puberty in girls

    International Journal of Obesity, Vol. 45, Núm. 3, pp. 502-514

2019

  1. ANGPTL-4 is associated with obesity and lipid profile in children and adolescents

    Nutrients, Vol. 11, Núm. 6

2018

  1. 25-Hydroxyvitamin D levels of children are inversely related to adiposity assessed by body mass index

    Journal of Physiology and Biochemistry, Vol. 74, Núm. 1, pp. 111-118

  2. Circulating Pro-Uroguanylin Levels In Children And Their Relation To Obesity, Sex And Puberty

    Scientific Reports, Vol. 8, Núm. 1

  3. Plasma ANGPTL-4 is Associated with Obesity and Glucose Tolerance: Cross-Sectional and Longitudinal Findings

    Molecular Nutrition and Food Research, Vol. 62, Núm. 10

2017

  1. Pharmacological inhibition of cannabinoid receptor 1 stimulates gastric release of nesfatin-1 via the mTOR pathway

    World Journal of Gastroenterology, Vol. 23, Núm. 35, pp. 6403-6411

2016

  1. FNDC5 is produced in the stomach and associated to body composition

    Scientific Reports, Vol. 6

  2. Regulation of Growth Hormone by the Splanchnic Area

    Progress in Molecular Biology and Translational Science (Elsevier B.V.), pp. 41-60

  3. Uroguanylin levels in intestine and plasma are regulated by nutritional status in a leptin-dependent manner

    European Journal of Nutrition, Vol. 55, Núm. 2, pp. 529-536

2015

  1. Peripheral signals mediate the beneficial effects of gastric surgery in obesity

    Gastroenterology Research and Practice, Vol. 2015

  2. Regulation of NUCB2/nesfatin-1 production in rat's stomach and adipose tissue is dependent on age, testosterone levels and lactating status

    Molecular and Cellular Endocrinology, Vol. 411, pp. 105-112

2014

  1. Drug development strategies for the treatment of obesity: How to ensure efficacy, safety, and sustainable weight loss

    Drug Design, Development and Therapy, Vol. 8, pp. 2391-2400

2013

  1. The gastric CB1 receptor modulates ghrelin production through the mTOR pathway to regulate food intake

    PLoS ONE, Vol. 8, Núm. 11